Pulmonx Corp. (LUNG)
2.065
-0.02
(-0.72%)
USD |
NASDAQ |
Sep 09, 13:07
Pulmonx Profit Margin (Quarterly) : -44.30% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.30% |
| March 31, 2026 | -66.33% |
| December 31, 2025 | -46.13% |
| September 30, 2025 | -64.91% |
| June 30, 2025 | -63.59% |
| March 31, 2025 | -64.11% |
| December 31, 2024 | -55.44% |
| September 30, 2024 | -69.38% |
| June 30, 2024 | -73.74% |
| March 31, 2024 | -72.92% |
| December 31, 2023 | -72.04% |
| September 30, 2023 | -84.33% |
| June 30, 2023 | -94.19% |
| March 31, 2023 | -109.1% |
| December 31, 2022 | -92.60% |
| Date | Value |
|---|---|
| September 30, 2022 | -105.0% |
| June 30, 2022 | -104.9% |
| March 31, 2022 | -146.8% |
| December 31, 2021 | -94.88% |
| September 30, 2021 | -76.77% |
| June 30, 2021 | -106.2% |
| March 31, 2021 | -135.4% |
| December 31, 2020 | -94.58% |
| September 30, 2020 | -36.37% |
| June 30, 2020 | -324.3% |
| March 31, 2020 | -83.12% |
| December 31, 2019 | -45.12% |
| September 30, 2019 | -47.62% |
| June 30, 2019 | -75.63% |
| March 31, 2019 | -106.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -89.70% |
| Return on Assets | -36.78% |
| Return on Invested Capital | -43.71% |
| Gross Profit Margin (Quarterly) | 77.53% |
| Operating Margin (Quarterly) | -39.80% |
| Return on Net Operating Assets | -87.66% |